BioSpace News Archive

FDA

Quoin Pharmaceuticals Announces FDA Clearance of Clinical Optimization Plan for QRX003 for Netherton Syndrome

Quoin Pharmaceuticals Ltd. today announced that it has received U.S. Food and Drug Administration (FDA) clearance to implement a number of protocol amendments to its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS).

December 13, 2023
·
5 min read
Business

SeaStar Medical Forms Scientific Advisory Board of World-Renowned Pediatric and Adult Clinical Experts

SeaStar Medical Holding Corporation announces the formation of the SeaStar Medical Scientific Advisory Board (SAB). The SAB is comprised of world-renowned international pediatric and adult clinical experts.

December 13, 2023
·
6 min read
FDA Breakthrough Device using Optical Spectroscopy was Found to Significantly Increase Physicians’ Detection of Skin Cancer

DermaSensor Inc ., the pioneer of the first point-and-click skin cancer detection device for primary care physicians, announces the publication of a new study 1 in the Journal of Primary Care and Community Health.

December 13, 2023
·
4 min read
BioCapital

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Processa Pharmaceuticals, Inc. announces the outcomes from a successful meeting with the U.S. Food and Drug Administration (“FDA”) regarding the Company’s next Phase 2 study supporting the advancement of Next Generation Capecitabine (“NGC-Cap”) for cancer patients.

December 13, 2023
·
4 min read
FDA

Xpan secures FDA 510(k) clearance and announces successful completion of initial human clinical cases in the United States

Xpan Inc., a medical device company focused on minimally invasive surgical innovation, is proud to announce 510(k) clearance from the U.S. Food & Drug Administration for the XpanTM Universal Trocar System, and successful completion of initial clinical procedures in the United States.

December 13, 2023
·
2 min read
Deals

CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering

CytoSorbents Corporation today announces the closing of its previously announced registered direct offering for the sale by the Company directly to investors of an aggregate of 7,733,090 shares of registered common stock.

December 13, 2023
·
6 min read
Business

Propanc Biopharma’s Joint Research Partner Pushing Boundaries to Circumvent Chemotherapy Resistance Using PRP

Propanc Biopharma, Inc. today announced that the Company’s joint researcher, Mrs. Belén Toledo Cutillas, has commenced an internship at the Cancer Center Amsterdam – vUMC (University Medical Centers).

December 13, 2023
·
4 min read
Epigenetics Market Size to Reach USD 6.35 Bn By 2032

The global epigenetics market size is projected to reach around USD 6.35 billion by 2032, increasing from USD 2.14 billion in 2023 and is expanding at a healthy CAGR of 12.82% between 2023 to 2032.

December 13, 2023
·
11 min read
Biotech Beach

NeuroQure Acquires Patents to Detect Autism in Newborns with a Skin Sample

NeuroQure, a pioneering biotech startup specializing in gene therapy for neurocognitive disorders, has reached a pivotal milestone in the development of its first commercial product.

December 13, 2023
·
4 min read
Preclinical CRO Market Poised to Surge USD 10.60 Bn by 2032

The global preclinical CRO market size was exhibited at USD 5.33 billion in 2022 and is projected to hit around USD 10.60 billion by 2032, growing at a CAGR of 7.11% during the forecast period 2023 to 2032.

December 13, 2023
·
7 min read